# Ligong Lu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ligong-lu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,229 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 53 |
| i10-index | 171 |
| Last Known Institution | Jinan University |
| OpenAlex ID | https://openalex.org/A5023266686 |
| ORCID iD | 0000-0003-1405-0052 |
| Works | 306 |

## Researcher papers

- [Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-hepatocellular-carcinoma-2019/)
- [Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study](https://scholariq.org/papers/brivanib-versus-sorafenib-as-first-line-therapy-in-patients-with-unresectable/)
- [Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)](https://scholariq.org/papers/guidelines-for-diagnosis-and-treatment-of-primary-liver-cancer-in-china-2017/)
- [Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model](https://scholariq.org/papers/exosomes-from-adipose-derived-stem-cells-overexpressing-nrf2-accelerate/)
- [Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-primary-liver-cancer-2022-edition/)
- [Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy](https://scholariq.org/papers/near-infrared-ii-phototherapy-induces-deep-tissue-immunogenic-cell-death-and/)
- [γδ T cells: origin and fate, subsets, diseases and immunotherapy](https://scholariq.org/papers/t-cells-origin-and-fate-subsets-diseases-and-immunotherapy/)
- [Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial](https://scholariq.org/papers/brivanib-as-adjuvant-therapy-to-transarterial-chemoembolization-in-patients-with/)
- [A Potential Role of Interleukin 10 in COVID-19 Pathogenesis](https://scholariq.org/papers/a-potential-role-of-interleukin-10-in-covid-19-pathogenesis/)
- [Early triage of critically ill COVID-19 patients using deep learning](https://scholariq.org/papers/early-triage-of-critically-ill-covid-19-patients-using-deep-learning/)
- [A Propensity Score Matching Study Between Microwave Ablation and Radiofrequency Ablation in Terms of Safety and Efficacy for Benign Thyroid Nodules Treatment](https://scholariq.org/papers/a-propensity-score-matching-study-between-microwave-ablation-and-radiofrequency/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Jinan University](https://scholariq.org/institutions/jinan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.